TITLE

Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs

AUTHOR(S)
Kerckhoffs, Angèle P. M.; Akkermans, Louis M. A.; de Smet, Martin B. M.; Besselink, Marc G. H.; Hietbrink, Falco; Bartelink, Imke H.; Busschers, Wim B.; Samsom, Melvin; Renooij, Willem; Kerckhoffs, Angèle P M
PUB. DATE
March 2010
SOURCE
Digestive Diseases & Sciences;Mar2010, Vol. 55 Issue 3, p716
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Intestinal permeability and the effect of NSAIDs on permeability were investigated in 14 irritable bowel syndrome (IBS) patients and 15 healthy subjects. In the study, 24-h urinary recoveries of orally administered polyethylene glycols (PEGs 400, 1500, and 4000) were not significantly different in healthy subjects and IBS patients before or after NSAID ingestion. Lactulose mannitol ratios in healthy subjects and IBS patients were not significantly different. Only time-dependent monitoring of PEG excretion showed that NSAIDs enhanced intestinal permeability for PEG 4000 in healthy subjects (P = 0.050) and for PEGs 400, 1500, and 4000 in IBS patients (P = 0.012, P = 0.041, and P = 0.012, respectively). These results show that intestinal permeability in IBS patients is not different from that in healthy subjects; NSAIDs compromise intestinal permeability in IBS patients to a greater extent than in healthy subjects, which suggests that IBS is associated with an altered response of the intestinal barrier to noxious agents.
ACCESSION #
48111293

 

Related Articles

  • Abnormal Intestinal Permeability in Subgroups of Diarrhea-Predominant Irritable Bowel Syndromes. Dunlop, Simon P.; Hebden, John; Campbell, Eugene; Naesdal, Jorgen; Olbe, Lars; Perkins, Alan C.; Spiller, Robin C. // American Journal of Gastroenterology;Jun2006, Vol. 101 Issue 6, p1288 

    OBJECTIVES: Irritable bowel syndrome (IBS) is a heterogeneous condition and defined according to symptoms. Low-grade inflammation has been associated with IBS, particularly that following infection, but whether altered intestinal permeability profiles relate to irritable bowel subtype or onset...

  • Response to Drs Shearer and Ford. Chapman, R W; Stanghellini, V; Geraint, M; Halphen, M // American Journal of Gastroenterology;Jan2014, Vol. 109 Issue 1, p136 

    A letter to the editor is presented in response to the article related to role of polyethylene glycol in constipation-predominant irritable bowel syndrome that was published in a 2014 issue of the periodical.

  • When You Hear Hoof Beats, Sometimes You Have to Think of Zebras. Wilke, Allan J. // Internal Medicine Alert;6/15/2009, Vol. 31 Issue 11, p81 

    IRRITABLE BOWEL SYNDROME (IBS) AND CELIAC DISEASE (CD) SHARE many of the same symptoms, including abdominal pain, diarrhea, and bloating. IBS is more common with a prevalence of 7-10%;1 CD is an order of magnitude less.2 Since CD has a specific therapy, namely elimination of gluten from the...

  • GUT FEELING.  // Working Mother;May2000, p92 

    Informs on the percentage of Americans who suffer from irritable bowel syndrome, and the percentage of women sufferers.

  • The Overlap between Irritable Bowel Syndrome and Non-Celiac Gluten Sensitivity: A Clinical Dilemma. Makharia, Archita; Makharia, Govind K.; Catassi, Carlo // Nutrients;Dec2015, Vol. 7 Issue 12, p10417 

    The spectrum of gluten-related disorders has widened in recent times and includes celiac disease, non-celiac gluten sensitivity, and wheat allergy. The complex of symptoms associated with these diseases, such as diarrhea, constipation or abdominal pain may overlap for the gluten related...

  • Prevalence of irritable bowel syndrome in a non-Western population. Danivat, D.; Tankeyoon, M.; Sriratanaban, A. // British Medical Journal (Clinical Research Edition);6/18/1988, Vol. 296 Issue 6638, p1710 

    Examines the prevalence of irritable bowel syndrome in Thailand. Consideration of irritable bowel syndrome as one of the most common gastrointestinal disorders; Comparison between the stool frequency in rural and urban areas; Influence of stress on the prevalence of the irritable bowel syndrome...

  • Irritable Bowel Syndrome.  // American Family Physician;9/15/1996, Vol. 54 Issue 4, p1380 

    Discusses irritable bowel syndrome. Causes; Characteristics; Signs and symptoms; The need for thorough history-taking.

  • Randomized Clinical Trial: Macrogol/PEG 3350 Plus Electrolytes for Treatment of Patients With Constipation Associated With Irritable Bowel Syndrome. Chapman, R W; Stanghellini, V; Geraint, M; Halphen, M // American Journal of Gastroenterology;Sep2013, Vol. 108 Issue 9, p1508 

    OBJECTIVES:Polyethylene glycol (PEG) 3350 plus electrolytes (PEG 3350+E) is an established treatment for constipation and has been proposed as a treatment option for constipation associated with irritable bowel syndrome (IBS-C). This study aimed to compare the efficacy and safety of PEG 3350+E...

  • Dexamethasone prevents visceral hyperalgesia but not colonic permeabilily increase induced by luminal protease-activated receptor-2 agonist in rats. Róka, Richard; Ait-Belgnaoui, Afifa; Salvador-Cartier, Christel; Garcia-Villar, Raphael; Fioramonti, Jean; Eutamëne, Hélëne; Bueno, Lionel // Gut;Aug2007, Vol. 56 Issue 8, p1072 

    Background: Low-grade inflammation may play a role in the pathogenesis of irritable bowel syndrome (IBS). Although corticosteroids are potent inhibitors of inflammatory processes, only one study with corticosteroids in patients with postinfectious lBS exists, which suggests that prednisolone is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics